Another study on melanomas by Tumeh et al. showed that pre-existing CD8+ T cells located at the invasive tumor margin were associated with the expression of PD-1/PD-L1 immune inhibitory system and may predict response to anti-PD-L1 therapy [7]. The gene discussed is PDCD1; the disease is neoplasm.